Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT04887805
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2021-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-06
First Submit QC Date:
None
Study First Post Date:
2021-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-19
Last Update Post Date Type:
ESTIMATED